Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

CAN

  • Home
  •  
  • CAN



  • Most Read
  • Latest Comments
  • ‘Please explain’, social media post leads to flurry of ‘unusual’ cannabis trading
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • ‘Please explain’, social media post leads to flurry of ‘unusual’ cannabis trading
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • ‘Please explain’, social media post leads to flurry of ‘unusual’ cannabis trading
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • ‘Please explain’, social media post leads to flurry of ‘unusual’ cannabis trading
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • ‘Please explain’, social media post leads to flurry of ‘unusual’ cannabis trading
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • Melodiol’s Health House Australia enlists supplier, prepares for the launch of a medical cannabis clinic
    Melodiol’s Health House Australia enlists supplier, prepares for the launch of a medical cannabis clinic
    • News

  • ECS Botanics secures exclusive supply agreement with MediCann for $24 million worth of cannabis flowers
    ECS Botanics secures exclusive supply agreement with MediCann for $24 million worth of cannabis flowers
    • News

  • Cann Group poised for growth as demand for locally produced cannabis surges
    Cann Group poised for growth as demand for locally produced cannabis surges
    • News

  • Cann Group strengthens position with variation agreement in medicinal cannabis sector
    Cann Group strengthens position with variation agreement in medicinal cannabis sector
    • News

  • Cannabis company comeback, Cann Group’s busy few months
    Cannabis company comeback, Cann Group’s busy few months
    • News

  • ‘Please explain’, social media post leads to flurry of ‘unusual’ cannabis trading
    • News

    ‘Please explain’, social media post leads to flurry of ‘unusual’ cannabis trading

    Medical cannabis producer, Cann Group Limited (ASX: CAN) have announced this morning their response to yesterday’s price query from the ASX that lead to the company being placed in a trading halt soon after. The regulator probed the company to ‘please explain’ yesterday’s trading activity which saw almost a 19% increase in trading price and

    Read More
    Public

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.